May 15 (Reuters) - Amneal Pharmaceuticals ( AMRX ) said
on Thursday the U.S. Food and Drug Administration has approved
its self-administered migraine drug.
(Reporting by Mariam Sunny in Bengaluru; Editing by Devika
Syamnath)